Home › Myasthenia Gravis › New Jersey
Myasthenia Gravis clinical trials in New Jersey
3 studies for Myasthenia Gravis are looking for participants at sites in New Jersey.
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1019, Totowa
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Jul 30, 2026 · NCT07039916A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab
- Research Site, Neptune City
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Apr 9, 2026 · NCT07221838Vitaccess Real MG Registry
- Neurology Associates of South Jersey, Lumberton
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jul 29, 2025 · NCT06064461From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.